INCYTE CORP
INCYHealthcareincyte.com
Latest available resultsSeptember 30, 2026Quarter · 10-Q filed Oct 29, 2026
Next reportFebruary 8, 2027after close · forecast 2.038 $/share
Revenue
$1.56B
▲ +14.0% vs prior year YoY
Net income
−$784.80M
▼ -285.0% vs prior year YoY
EPS
-3.86$
▼ -282.9% vs prior year YoY
Net margin
-50.4%
▼ -81.5 pp vs prior year YoY
Revenue▲ +14.0%
Margins (% of revenue)GrossOperatingNet
Net income▼ -285.0%
EPS▼ -282.9%
Financial statements
View 10-Q filed October 29, 2026 on SEC ↗| Metric | Dec 2024* | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025* | Mar 2026 | Jun 2026 | Sep 2026 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Operations | |||||||||
| Revenue | $1.18B | $1.05B | $1.22B | $1.37B | $1.51B | $1.27B | $1.67B | $1.56B | ▲ +14.0% |
| Gross profit | $1.09B | $979.71M | $1.14B | $1.27B | $1.39B | $1.17B | $1.57B | $1.45B | ▲ +14.3% |
| Operating income | $301.51M | $205.17M | $530.31M | $443.52M | $335.86M | $301.12M | $697.90M | −$708.36M | ▼ -259.7% |
| Net income | $201.21M | $158.20M | $405.00M | $424.17M | $299.28M | $303.33M | $585.61M | −$784.80M | ▼ -285.0% |
| R&D | $466.03M | $437.28M | $494.92M | $506.58M | $611.37M | $515.90M | $516.95M | $1.79B | ▲ +253.7% |
| EPS (diluted) | — | 0.80 $ | 2.04 $ | 2.11 $ | — | 1.47 $ | 2.81 $ | -3.86 $ | ▼ -282.9% |
| Margins (% of revenue) | |||||||||
| Gross | 92.5 % | 93.0 % | 93.5 % | 92.8 % | 92.0 % | 91.8 % | 93.7 % | 93.0 % | ▲ +0.3 pt |
| Operating | 25.6 % | 19.5 % | 43.6 % | 32.5 % | 22.3 % | 23.7 % | 41.7 % | -45.5 % | ▼ -78.0 pt |
| Net | 17.1 % | 15.0 % | 33.3 % | 31.1 % | 19.9 % | 23.8 % | 35.0 % | -50.4 % | ▼ -81.5 pt |
| Balance sheet | |||||||||
| Assets | $5.44B | $5.75B | $5.82B | $6.33B | $6.96B | $7.34B | $7.87B | $7.29B | ▲ +15.1% |
| Liabilities | $2.00B | $2.08B | $1.65B | $1.68B | $1.79B | $1.72B | $1.53B | $1.64B | ▼ -2.1% |
| Equity | $3.45B | $3.67B | $4.17B | $4.65B | $5.17B | $5.62B | $6.34B | $5.64B | ▲ +21.3% |
| Cash | $1.69B | $1.94B | $1.95B | $2.46B | $3.10B | $3.46B | $3.98B | $3.28B | ▲ +33.4% |
| Capital | |||||||||
| Shares outstanding | 193.52M | 193.57M | 195.28M | 196.32M | 199.01M | 199.78M | 202.70M | 203.83M | ▲ +3.8% |
| Public floatexcluding insiders | — | — | — | — | — | — | — | — | — |
* No 10-Q is filed for a fourth quarter: these amounts are the fiscal year minus the first three quarters, all filed. EPS stays blank — dilution doesn't subtract.